This inventor holds 16 USPTO granted patents and 16 published patent applications, plus 8 CIPO patents and 10 EPO patents, primarily in Immunogenic Compositions. Top assignees: Glaxosmithkline Biologicals Sa, Glaxosmithkline LLC, The Ohio State University. Active years: 2010-2022.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
15 out of 545 
1 out of 358 
1 out of 1,584 
Years Active: 2010-2022
Areas of Expertise:
Title: The Innovative Mind of Philippe Denoel
Introduction
Philippe Denoel is a pioneering inventor based in Rixensart, Belgium, known for his substantial contributions to the field of immunogenic compositions. With a remarkable portfolio of 16 patents, Denoel's work has significantly influenced vaccine development and immunological research.
Latest Patents
Denoel's recent patents include advanced immunogenic compositions designed to enhance vaccine efficacy. One notable application discloses an immunogenic composition comprising capsular polysaccharides from serogroups A, C, W135, and Y, which are conjugated to a carrier protein. This formulation aims to produce a capsular polysaccharide conjugate, specifically engineered to ensure that the average size of each polysaccharide is above 50 kDa. Another innovative application outlines a composition that includes at least two different capsular saccharides selected from a specific group, which are conjugated either through a linker or directly to a carrier protein.
Career Highlights
Throughout his career, Philippe Denoel has collaborated with leading organizations to advance his research. He has held key positions at GlaxoSmithKline Biologicals SA and The Ohio State University, where he has been instrumental in the development of vaccines and immunological products.
Collaborations
Denoel has worked alongside distinguished colleagues during his career, including Jan Poolman and Ralph Leon Biemans. These collaborations have allowed him to share insights and accelerate the progress of his innovative projects, leading to the successful development of multiple patents.
Conclusion
Philippe Denoel stands out as an influential inventor whose work in immunogenic compositions continues to impact public health and vaccine strategies. His dedication to innovation in immunology not only showcases his expertise but also embodies the spirit of scientific advancement that is critical for addressing global health challenges.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile